Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Buy
1,189
+534
+82% +$850K 0.02% 259
2026
Q1
$865K Hold
655
0.01% 297
2025
Q4
$701K Hold
655
0.01% 304
2025
Q3
$634K Buy
+655
New +$515K ﹤0.01% 313
2022
Q2
Sell
-345
Closed -$230K 368
2022
Q1
$230K Buy
+345
New +$231K ﹤0.01% 374

Other funds holding ASML

Boston Trust Walden's ASML Position: Q2 2026 in Review

Boston Trust Walden increased its ASML (ASML) stake by 82% in Q2 2026, buying an estimated $850K and bringing the position to 1,189 shares worth $2.37M. The position accounts for 0.02% of the portfolio, ranked #259.

Boston Trust Walden first reported a position in ASML in Q1 2022 and has held it in 5 quarters since. 1,052 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Boston Trust Walden held 1,189 shares of ASML worth $2.37M as of Q2 2026.
  • Boston Trust Walden bought 534 ASML shares in Q2 2026, an estimated $850K.
  • ASML made up 0.02% of Boston Trust Walden's portfolio in Q2 2026, its #259 holding.
  • Boston Trust Walden first reported a position in ASML in Q1 2022 and has held it in 5 quarters since.
  • 1,052 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.